Isosorbide mononitrate and Orgovyx drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among 11 people who take Isosorbide mononitrate and Orgovyx. Common interactions include abdominal distension among males.

The phase IV clinical study analyzes what interactions people who take Isosorbide mononitrate and Orgovyx have. It is created by eHealthMe based on reports from the FDA, and is updated regularly. You may use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Sep, 29, 2023

11 people who take Isosorbide mononitrate and Orgovyx together, and have interactions are studied.


What is Isosorbide mononitrate?

Isosorbide mononitrate has active ingredients of isosorbide mononitrate. It is used in angina. Currently, eHealthMe is studying from 25,447 Isosorbide mononitrate users.

What is Orgovyx?

Orgovyx has active ingredients of relugolix. Currently, eHealthMe is studying from 4,370 Orgovyx users.

Number of Isosorbide mononitrate and Orgovyx reports submitted per year:

Isosorbide mononitrate and Orgovyx drug interactions.

Common Isosorbide Mononitrate and Orgovyx drug interactions by gender *:

female:

n/a

male:

  1. Abdominal distension
  2. Arthralgia
  3. Anaemia
  4. Blood glucose increased
  5. Death
  6. Hot flush
  7. Diarrhoea
  8. Fatigue
  9. Flatulence
  10. Nausea

Common Isosorbide Mononitrate and Orgovyx drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

  1. Abdominal distension
  2. Arthralgia
  3. Diarrhoea
  4. Fatigue
  5. Flatulence
  6. Nausea
  7. Fall
  8. Hyponatraemia
  9. Death

Common conditions people have *:

  1. Prostate Cancer: 11 people, 100.00%
  2. High Blood Cholesterol: 5 people, 45.45%
  3. Cardiac Disorder: 4 people, 36.36%
  4. Pain: 2 people, 18.18%
  5. High Blood Pressure: 2 people, 18.18%
  6. Sleep Disorder: 1 person, 9.09%
  7. Fluid Retention (an abnormal accumulation of fluid in the blood): 1 person, 9.09%
  8. Bone Disorder: 1 person, 9.09%
  9. Breathing Difficulty: 1 person, 9.09%
  10. Chest Pain: 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Isosorbide mononitrate and Orgovyx?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

Drug side effects by duration, gender and age:

Common Isosorbide mononitrate drug interactions:

Browse interactions between Isosorbide mononitrate and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Orgovyx drug interactions:

Browse interactions between Orgovyx and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on isosorbide mononitrate and relugolix (the active ingredients of Isosorbide mononitrate and Orgovyx, respectively), and Isosorbide mononitrate and Orgovyx (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Isosorbide mononitrate and Orgovyx.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: